DK0633260T3 - 2,3-Dihydro-1,4-benzodioxan-5-yl-piperazinderivater med 5-HT1A-antagonistisk aktivitet - Google Patents

2,3-Dihydro-1,4-benzodioxan-5-yl-piperazinderivater med 5-HT1A-antagonistisk aktivitet

Info

Publication number
DK0633260T3
DK0633260T3 DK94201900T DK94201900T DK0633260T3 DK 0633260 T3 DK0633260 T3 DK 0633260T3 DK 94201900 T DK94201900 T DK 94201900T DK 94201900 T DK94201900 T DK 94201900T DK 0633260 T3 DK0633260 T3 DK 0633260T3
Authority
DK
Denmark
Prior art keywords
antagonistic activity
benzodioxan
dihydro
piperazine derivatives
ht1a
Prior art date
Application number
DK94201900T
Other languages
Danish (da)
English (en)
Inventor
Jan Hartog
Steen B J Van
Johannes Mos
Jacques Schipper
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of DK0633260T3 publication Critical patent/DK0633260T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DK94201900T 1993-07-05 1994-07-01 2,3-Dihydro-1,4-benzodioxan-5-yl-piperazinderivater med 5-HT1A-antagonistisk aktivitet DK0633260T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93201950 1993-07-05

Publications (1)

Publication Number Publication Date
DK0633260T3 true DK0633260T3 (da) 2002-02-25

Family

ID=8213949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94201900T DK0633260T3 (da) 1993-07-05 1994-07-01 2,3-Dihydro-1,4-benzodioxan-5-yl-piperazinderivater med 5-HT1A-antagonistisk aktivitet

Country Status (21)

Country Link
US (1) US5462942A (zh)
EP (1) EP0633260B1 (zh)
JP (1) JP3572102B2 (zh)
KR (1) KR100363988B1 (zh)
CN (1) CN1044244C (zh)
AT (1) ATE208385T1 (zh)
AU (1) AU680900B2 (zh)
CA (1) CA2127084C (zh)
CZ (1) CZ286503B6 (zh)
DE (1) DE69428943T2 (zh)
DK (1) DK0633260T3 (zh)
ES (1) ES2167346T3 (zh)
FI (1) FI120306B (zh)
HU (1) HU218215B (zh)
IL (1) IL110209A (zh)
NO (1) NO301980B1 (zh)
NZ (1) NZ260891A (zh)
PT (1) PT633260E (zh)
RU (1) RU2118322C1 (zh)
SK (1) SK281681B6 (zh)
ZA (1) ZA944787B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2213192A1 (en) * 1995-02-23 1996-08-29 Merck & Co., Inc. Alpha.1a. adrenergic receptor antagonists
US6096763A (en) * 1995-02-23 2000-08-01 Merck & Co., Inc. α1a adrenergic receptor antagonists
US5952351A (en) * 1995-02-23 1999-09-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US5620997A (en) * 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
AU7734496A (en) * 1995-11-15 1997-06-05 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
US6001863A (en) * 1996-11-26 1999-12-14 Warner-Lambert Company Isothiazolones
TW530054B (en) * 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds
US6177566B1 (en) 1998-06-30 2001-01-23 Neurogen Corporation 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands
AR022303A1 (es) 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
CN1081128C (zh) * 1999-08-18 2002-03-20 湖北省化学研究所 软性印刷电路板专用的高分子塑料薄膜双面复合金属板的制造方法
DE10031391A1 (de) * 2000-07-03 2002-02-07 Knoll Ag Bicyclische Verbindungen und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
JP5080716B2 (ja) 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
KR20030084444A (ko) * 2002-04-26 2003-11-01 주식회사 파나진 Pna 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
US20040215284A1 (en) * 2003-01-30 2004-10-28 Recordati S.A. Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
CN111253335B (zh) * 2020-03-12 2023-06-06 浙江扬帆新材料股份有限公司 一种n-取代苯并异噻唑啉-3-酮衍生物的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519986A1 (fr) * 1982-01-21 1983-07-22 Adir Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
AU577802B2 (en) * 1983-10-17 1988-10-06 Duphar International Research B.V. Blood-pressure lowering piperazine derivatives
EP0190472B1 (en) * 1984-12-21 1989-07-12 Duphar International Research B.V New pharmaceutical compositions having anti-psychotic properties
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3726425A1 (de) * 1987-03-18 1988-09-29 Bayer Ag Basisch substituierte saccharine
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
NZ231631A (en) * 1988-12-08 1992-07-28 Duphar Int Res Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JPH02184667A (ja) * 1989-01-11 1990-07-19 Meiji Seika Kaisha Ltd N,n’―ジ置換ピペラジル誘導体及びそれを有効成分とする排尿障害改善剤
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds

Also Published As

Publication number Publication date
CZ286503B6 (en) 2000-04-12
JP3572102B2 (ja) 2004-09-29
ZA944787B (en) 1995-02-20
NO942471D0 (no) 1994-06-30
CA2127084C (en) 2007-04-10
HU9401965D0 (en) 1994-09-28
CN1044244C (zh) 1999-07-21
HU218215B (hu) 2000-06-28
NO301980B1 (no) 1998-01-05
HUT75155A (en) 1997-04-28
RU94023250A (ru) 1996-08-10
CZ159794A3 (en) 1995-05-17
EP0633260B1 (en) 2001-11-07
US5462942A (en) 1995-10-31
KR100363988B1 (ko) 2003-02-05
CA2127084A1 (en) 1995-01-06
NZ260891A (en) 1995-04-27
SK78894A3 (en) 1995-03-08
IL110209A0 (en) 1994-10-21
DE69428943D1 (de) 2001-12-13
PT633260E (pt) 2002-04-29
SK281681B6 (sk) 2001-06-11
RU2118322C1 (ru) 1998-08-27
AU680900B2 (en) 1997-08-14
IL110209A (en) 2000-02-29
ES2167346T3 (es) 2002-05-16
CN1106813A (zh) 1995-08-16
ATE208385T1 (de) 2001-11-15
AU6613994A (en) 1995-01-12
NO942471L (no) 1995-01-06
FI943149A0 (fi) 1994-06-30
FI120306B (fi) 2009-09-15
KR950003289A (ko) 1995-02-16
DE69428943T2 (de) 2002-08-01
FI943149A (fi) 1995-01-06
JPH07215972A (ja) 1995-08-15
EP0633260A1 (en) 1995-01-11

Similar Documents

Publication Publication Date Title
DK0633260T3 (da) 2,3-Dihydro-1,4-benzodioxan-5-yl-piperazinderivater med 5-HT1A-antagonistisk aktivitet
ES2054899T3 (es) Derivados de 2'-desoxi-5-fluorouridina.
ES2188095T3 (es) Carboxamidas heterociclicas.
DE3574968D1 (de) 11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate.
ATE126509T1 (de) Disäuren von diarylstyrylchinolin.
DE69717970T2 (de) Chinolin carbonsaure-derivate und ihre salze
ES2088410T3 (es) Fungicidas de acrilato.
PE20001083A1 (es) Derivados de mononitrato de isosorbide
ES551337A0 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
DE69919436D1 (de) N-Acyl und N-Aroyl Aralkylamide
ATE89003T1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
CA2273303A1 (en) Thienylsulfonylamino(thio)carbonyl compounds
ATE139772T1 (de) Aromatische amine derivate von 2,5-dimercapto- 1,3,4-thiadiazolen.
DE69119282D1 (de) Aminobenzolverbindungen, Herstellung und Verwendung
ATE42549T1 (de) Bis(arylpiperazinyl)-schwefelverbindungen.
FR2635523B1 (fr) Procede de preparation de diarylsulfures
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
PT81878B (pt) Processo para a preparacao de 5-aril-di-hidropiridinas uteis como medicamentos
DE69213049T2 (de) Isoquinolinderivate
TH5599A (th) อนุพันธุ์ของคาร์บาโมอิลลอกซีไธโอฟีน